Trending Stock News

Vontobel Asset Management Trimmed Abbott Labs (ABT) Position by $784,759 as Stock Price Rose; Capital Wealth Planning Holding in Archer Daniels Midland Co (ADM) Lowered by $306,720 as Stock Rose

Archer-Daniels-Midland Company (NYSE:ADM) Logo

Vontobel Asset Management Inc decreased its stake in Abbott Labs (ABT) by 0.42% based on its latest 2017Q4 regulatory filing with the SEC. Vontobel Asset Management Inc sold 13,301 shares as the company’s stock rose 5.88% while stock markets declined. The institutional investor held 3.12M shares of the major pharmaceuticals company at the end of 2017Q4, valued at $184.18 million, down from 3.13 million at the end of the previous reported quarter. Vontobel Asset Management Inc who had been investing in Abbott Labs for a number of months, seems to be less bullish one the $109.07B market cap company. The stock increased 0.81% or $0.5 during the last trading session, reaching $62.21. About 1.36M shares traded. Abbott Laboratories (NYSE:ABT) has risen 34.85% since May 21, 2017 and is uptrending. It has outperformed by 23.30% the S&P500.

Capital Wealth Planning Llc decreased its stake in Archer Daniels Midland Co (ADM) by 38.98% based on its latest 2017Q4 regulatory filing with the SEC. Capital Wealth Planning Llc sold 7,668 shares as the company’s stock rose 6.67% while stock markets declined. The institutional investor held 12,005 shares of the packaged foods company at the end of 2017Q4, valued at $481,000, down from 19,673 at the end of the previous reported quarter. Capital Wealth Planning Llc who had been investing in Archer Daniels Midland Co for a number of months, seems to be less bullish one the $25.16B market cap company. It closed at $45.02 lastly. It is down 5.47% since May 21, 2017 and is downtrending. It has underperformed by 17.02% the S&P500.

Another recent and important Archer-Daniels-Midland Company (NYSE:ADM) news was published by Seekingalpha.com which published an article titled: “Ethanol Is Too Cheap” on April 30, 2018.

Among 17 analysts covering Archer Daniels Midland Company (NYSE:ADM), 7 have Buy rating, 2 Sell and 8 Hold. Therefore 41% are positive. Archer Daniels Midland Company had 56 analyst reports since July 29, 2015 according to SRatingsIntel. The stock of Archer-Daniels-Midland Company (NYSE:ADM) has “Hold” rating given on Monday, January 22 by Stifel Nicolaus. The firm has “Hold” rating by Stifel Nicolaus given on Thursday, December 15. Citigroup upgraded Archer-Daniels-Midland Company (NYSE:ADM) on Tuesday, March 6 to “Buy” rating. Piper Jaffray initiated the stock with “Neutral” rating in Thursday, December 15 report. The stock of Archer-Daniels-Midland Company (NYSE:ADM) earned “Market Perform” rating by BMO Capital Markets on Wednesday, November 1. Argus Research downgraded the shares of ADM in report on Thursday, June 1 to “Hold” rating. The rating was maintained by Stifel Nicolaus on Tuesday, October 31 with “Hold”. On Wednesday, November 1 the stock rating was maintained by Monness Crespi with “Sell”. The firm has “Hold” rating given on Friday, February 12 by Argus Research. As per Friday, August 25, the company rating was maintained by Piper Jaffray.

Analysts await Archer-Daniels-Midland Company (NYSE:ADM) to report earnings on August, 7. They expect $0.75 earnings per share, up 31.58% or $0.18 from last year’s $0.57 per share. ADM’s profit will be $419.15 million for 15.01 P/E if the $0.75 EPS becomes a reality. After $0.68 actual earnings per share reported by Archer-Daniels-Midland Company for the previous quarter, Wall Street now forecasts 10.29% EPS growth.

Capital Wealth Planning Llc, which manages about $380.53 million and $72.55 million US Long portfolio, upped its stake in Procter & Gamble Co (NYSE:PG) by 4,489 shares to 22,129 shares, valued at $2.03M in 2017Q4, according to the filing.

Investors sentiment decreased to 1 in 2017 Q4. Its down 0.21, from 1.21 in 2017Q3. It dived, as 53 investors sold ADM shares while 201 reduced holdings. 75 funds opened positions while 180 raised stakes. 419.48 million shares or 0.49% more from 417.42 million shares in 2017Q3 were reported. Legal & General Group Plc stated it has 3.30M shares. Gabelli Funds Limited Liability holds 0.14% or 613,800 shares in its portfolio. Fuller Thaler Asset Mgmt Incorporated, a California-based fund reported 12,500 shares. Aqr Capital Limited Com accumulated 7.33M shares. Alabama-based Andra Ap has invested 0.07% in Archer-Daniels-Midland Company (NYSE:ADM). Lenox Wealth Incorporated reported 345 shares. Suntrust Banks Inc holds 0.02% or 81,938 shares. 567,889 are held by Sei. Brandywine Investment Ltd Liability Co holds 0% in Archer-Daniels-Midland Company (NYSE:ADM) or 1,842 shares. Indexiq Advsr Llc stated it has 0.06% in Archer-Daniels-Midland Company (NYSE:ADM). Arizona State Retirement has invested 0.06% in Archer-Daniels-Midland Company (NYSE:ADM). Cap One Association has invested 0.04% in Archer-Daniels-Midland Company (NYSE:ADM). Dowling & Yahnke Ltd Co owns 25,846 shares. Afam Capital holds 173,065 shares. 5,446 were reported by Raymond James Trust Na.

Since March 12, 2018, it had 0 insider buys, and 2 sales for $952,039 activity. Another trade for 399 shares valued at $17,749 was made by Cuddy Christopher M on Monday, March 12.

Investors sentiment increased to 0.91 in 2017 Q4. Its up 0.04, from 0.87 in 2017Q3. It improved, as 52 investors sold ABT shares while 558 reduced holdings. 123 funds opened positions while 430 raised stakes. 1.22 billion shares or 0.64% more from 1.21 billion shares in 2017Q3 were reported. Sumitomo Mitsui, Japan-based fund reported 5.06 million shares. Bbva Compass State Bank owns 231,276 shares. 4,648 are held by Tompkins Financial Corp. Chatham Grp invested 0.32% in Abbott Laboratories (NYSE:ABT). Westport Asset Mgmt owns 5,000 shares for 0.18% of their portfolio. Seabridge Invest Advisors Ltd Company owns 2,875 shares or 0.04% of their US portfolio. First Foundation Advisors stated it has 9,748 shares or 0.03% of all its holdings. Parsons Mgmt Ri holds 0.73% of its portfolio in Abbott Laboratories (NYSE:ABT) for 114,511 shares. Meeder Asset Inc, Ohio-based fund reported 31,692 shares. Independent owns 1.17% invested in Abbott Laboratories (NYSE:ABT) for 52,550 shares. Japan-based Nomura Asset Mgmt has invested 0.3% in Abbott Laboratories (NYSE:ABT). Boyd Watterson Asset Management Oh reported 1.14% stake. Moreover, Cornerstone has 3.05% invested in Abbott Laboratories (NYSE:ABT) for 314,869 shares. Glg Limited Company stated it has 115,021 shares. Investec Asset Mgmt holds 0.06% of its portfolio in Abbott Laboratories (NYSE:ABT) for 264,414 shares.

Analysts await Abbott Laboratories (NYSE:ABT) to report earnings on July, 19. They expect $0.71 EPS, up 14.52% or $0.09 from last year’s $0.62 per share. ABT’s profit will be $1.24B for 21.90 P/E if the $0.71 EPS becomes a reality. After $0.59 actual EPS reported by Abbott Laboratories for the previous quarter, Wall Street now forecasts 20.34% EPS growth.

Among 25 analysts covering Abbott Laboratories (NYSE:ABT), 18 have Buy rating, 0 Sell and 7 Hold. Therefore 72% are positive. Abbott Laboratories had 107 analyst reports since July 24, 2015 according to SRatingsIntel. JP Morgan maintained it with “Overweight” rating and $69 target in Thursday, January 25 report. Stifel Nicolaus maintained Abbott Laboratories (NYSE:ABT) rating on Thursday, October 19. Stifel Nicolaus has “Buy” rating and $63.0 target. Deutsche Bank maintained the stock with “Buy” rating in Friday, July 21 report. The firm has “Outperform” rating given on Monday, August 10 by Credit Suisse. Jefferies maintained the stock with “Buy” rating in Friday, June 16 report. Jefferies maintained Abbott Laboratories (NYSE:ABT) rating on Tuesday, September 5. Jefferies has “Buy” rating and $58.0 target. The stock of Abbott Laboratories (NYSE:ABT) earned “Buy” rating by Jefferies on Monday, December 7. The rating was maintained by Barclays Capital on Thursday, October 19 with “Overweight”. The firm earned “Buy” rating on Wednesday, June 21 by BTIG Research. The firm earned “Neutral” rating on Tuesday, September 22 by UBS.

Since December 14, 2017, it had 1 buy, and 20 sales for $23.69 million activity. On Wednesday, March 7 the insider Watkin Jared sold $183,579. $14.27M worth of Abbott Laboratories (NYSE:ABT) was sold by Fussell Stephen R. Shares for $50,397 were sold by Contreras Jaime on Monday, April 23. BIRD ROGER sold $518,450 worth of stock. Bracken Sharon J also sold $62,056 worth of Abbott Laboratories (NYSE:ABT) shares. Shares for $1.56 million were sold by Salvadori Daniel Gesua Sive on Thursday, December 14.

Vontobel Asset Management Inc, which manages about $44.19B and $14.03 billion US Long portfolio, upped its stake in British Amern Tob Plc (NYSEMKT:BTI) by 281,543 shares to 1.28M shares, valued at $85.91M in 2017Q4, according to the filing. It also increased its holding in Starbucks Corp (NASDAQ:SBUX) by 653,882 shares in the quarter, for a total of 4.42M shares, and has risen its stake in Medtronic Plc (NYSE:MDT).

Abbott Laboratories (NYSE:ABT) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *